MITOMYCIN 40 INJECTION contains Mitomycin which belongs to the group of medicines called Antineoplastic agents. MITOMYCIN 40 INJECTION is used in cancer therapy to manage and provide relief from symptoms of advanced/metastatic stomach, breast, and pancreatic cancer.
MITOMYCIN 40 INJECTION is also used to manage neck, respiratory tract, cervix, and rectal cancer. The medicine is also indicated for use to manage recurrence of bladder cancer following transurethral resection (surgery) in affected individuals.
MITOMYCIN 40 INJECTION is not recommended for use in patients allergic to Mitomycin. It is also not recommended for use in patients with pancytopenia (reduction in all types of blood cells), leukopenia (reduction in isolated white blood cells), thrombocytopenia (reduction in number of platelets), acute infection, and/or perforation in the bladder wall.
Before administering MITOMYCIN 40 INJECTION, inform your doctor if you suffer from a bad state of general heath, bone marrow depression, inflammation of urinary bladder, kidney, and/or liver disease.
MITOMYCIN 40 INJECTION is generally not recommended for use during pregnancy unless it is clearly necessary. Women of child-bearing potential should use contraceptive measures during and for at least next six months after stopping management with MITOMYCIN 40 INJECTION. The medicine is also not recommended for use in breast-feeding women.
MITOMYCIN 40 INJECTION is not recommended for use in children and adolescents (aged below 18 years) and is advised to be used with caution in elderly patients (aged 65 years/above) after consulting the doctor.
The most common side effects of receiving MITOMYCIN 40 INJECTION are loss of appetite, nausea, vomiting, diarrhoea, breathlessness, painful urination, and/or breathlessness. Consult your doctor if any of these side effects worsen.
No content available
